Assessment of the Clinical Effectiveness of a Herbal Extract (Cretan IAMA) in Patients With Viral Respiratory Infections, Including COVID-19, in Primary Healthcare Settings, and Co-assessment of Its Prophylactic Effect in People Cohabiting With These Patients
NCT04705753 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2021-01-12
Summary
This single-arm, open-label small interventional proof-of-concept (POC) study study aims:
1. to assess the clinical outcomes of patients exhibiting viral respiratory infection (VRI) symptoms and seeking primary healthcare (PHC) services at the time of the COVID-19 pandemic,
2. to assess the clinical effectiveness of the Cretan IAMA (CAPeo), a herbal extract combination, for these patients, including in terms of symptom resolution (symptom frequency, duration) and intensity), and
3. to investigate its prophylactic effect in terms of transmission prevention for people cohabiting with the patients exhibiting VRI symptoms.
Conditions
- Covid19
- Viral Infection
- Respiratory Viral Infection
Interventions
- DIETARY_SUPPLEMENT
-
Cretan IAMA
Cretan IAMA (CAPeo) soft gels, 1 ml/day of a 1.5% essential oil combination from three aromatic plants (Thymbra 59 capitata (L.) Cav., Origanum dictamnus L., Salvia fruticosa Mill.) in extra virgin olive oil
Sponsors & Collaborators
-
Galenica SA
collaborator UNKNOWN -
Olvos Science SA
collaborator UNKNOWN -
University of Crete
lead OTHER
Principal Investigators
-
Christos Lionis · University of Crete
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-04-01
- Primary Completion
- 2020-10-15
- Completion
- 2020-10-15
Countries
- Greece
Study Locations
More Related Trials
-
Evaluation of the Safety and Clinical Efficacy of NRICM102 in Patients With Chronic Lower Respiratory Tract Diseases
NCT06690203 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Lianhua Qingke for the Rehabilitation of Patient With Omicron Infection
NCT05625022 ·Status: UNKNOWN ·Phase: PHASE4
-
Treatment of Covid-19 With a Herbal Compound, Xagrotin
NCT05017493 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Randomized, Double-blind, Placebo-controlled Study on the Efficacy and Safety of CVT-E002 in the Treatment of Upper Respiratory Tract Infections in a Pediatric (3-11 Years) Population
NCT00965822 ·Status: COMPLETED ·Phase: PHASE2
-
Benefit and Tolerability of IQP-AS-105 in Reducing Susceptibility to Upper Respiratory Tract Infections
NCT01964885 ·Status: TERMINATED ·Phase: PHASE3
-
Single-center Clinical Study on the Safety and Effect of Bronchoscopic Cryotherapy in Patients With Chronic Cough
NCT06378671 ·Status: RECRUITING ·Phase: NA
-
Evaluation of KGR Prescriptions in Suppressing COVID-19 Infection.
NCT06291883 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy of an Extract of Concentrated Korean Red Ginseng for Preventing Upper Respiratory Tract Infections
NCT01478009 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Chinese Medicinal Herbs Treatment on Novel Influenza A (H1N1)Pneumonia: Multi-centre, Prospective, Randomized Controlled Study
NCT00936013 ·Status: UNKNOWN ·Phase: PHASE4
-
Effects of Traditional Chinese Medicine on Bronchiectasis Patients
NCT03443531 ·Status: UNKNOWN ·Phase: PHASE3
-
Effect of Intake of Allium Cepa L. Peel Heated Water Extract on Immunity Enhancement
NCT05666752 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of Echinacea for the Common Cold
NCT00032500 ·Status: COMPLETED ·Phase: PHASE2
-
A Pragmatic Randomized Controlled Trial of Chinese Herbal Medicine for Severe Pandemic H1N1 Influenza
NCT01053533 ·Status: UNKNOWN ·Phase: NA
-
Treatment and Prevention of Traditional Chinese Medicines (TCMs) on COVID-19 Infection
NCT04251871 ·Status: UNKNOWN ·Phase: NA
-
Trial of Chinese Herbal Medicine in the Treatment of Upper Respiratory Tract Infections (URTIs)
NCT00887172 ·Status: COMPLETED ·Phase: PHASE4
-
Randomized Controlled Clinical Trial to Evaluate The Efficacy and Safety of Healthtone as Prophylaxis for COVID-19
NCT05308615 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of Chinese Herbal Therapy for Asthma
NCT00712296 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Commercially Available Cannabis Products for Immune Support
NCT05944705 ·Status: RECRUITING
-
Trial to Study the Efficacy and Safety of BEJO Red Ginger in COVID-19 Patients With Mild Symptoms
NCT05277155 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Elderberry for Immune Support
NCT05435144 ·Status: UNKNOWN ·Phase: NA
-
Echinacea and Acute Respiratory Illness
NCT02003651 ·Status: COMPLETED ·Phase: NA
-
Green Tea Extract in Preventing Cancer in Former and Current Heavy Smokers With Abnormal Sputum
NCT00573885 ·Status: COMPLETED ·Phase: PHASE2
-
Andrographis Paniculata vs Boesenbergia Rotunda vs Control in Asymptomatic COVID-19
NCT05019326 ·Status: UNKNOWN ·Phase: PHASE3
-
A Clinical Trial to Evaluate the Efficacy and Safety of CKD-495
NCT04255589 ·Status: COMPLETED ·Phase: PHASE3
-
Complementary and Alternative Medicine Sauna Detoxification Study: Phase I
NCT01905098 ·Status: TERMINATED ·Phase: PHASE1